Skip to main content
Journal cover image

Risk factors, management, and clinical outcomes of invasive Mycoplasma and Ureaplasma infections after lung transplantation.

Publication ,  Journal Article
Tam, PCK; Hardie, R; Alexander, BD; Yarrington, ME; Lee, MJ; Polage, CR; Messina, JA; Maziarz, EK; Saullo, JL; Miller, R; Wolfe, CR; Arif, S ...
Published in: Am J Transplant
April 2024

Mollicute infections, caused by Mycoplasma and Ureaplasma species, are serious complications after lung transplantation; however, understanding of the epidemiology and outcomes of these infections remains limited. We conducted a single-center retrospective study of 1156 consecutive lung transplants performed from 2010-2019. We used log-binomial regression to identify risk factors for infection and analyzed clinical management and outcomes. In total, 27 (2.3%) recipients developed mollicute infection. Donor characteristics independently associated with recipient infection were age ≤40 years (prevalence rate ratio [PRR] 2.6, 95% CI 1.0-6.9), White race (PRR 3.1, 95% CI 1.1-8.8), and purulent secretions on donor bronchoscopy (PRR 2.3, 95% CI 1.1-5.0). Median time to diagnosis was 16 days posttransplant (IQR: 11-26 days). Mollicute-infected recipients were significantly more likely to require prolonged ventilatory support (66.7% vs 21.4%), undergo dialysis (44.4% vs 6.3%), and remain hospitalized ≥30 days (70.4% vs 27.4%) after transplant. One-year posttransplant mortality in mollicute-infected recipients was 12/27 (44%), compared to 148/1129 (13%) in those without infection (P <.0001). Hyperammonemia syndrome occurred in 5/27 (19%) mollicute-infected recipients, of whom 3 (60%) died within 10 weeks posttransplant. This study highlights the morbidity and mortality associated with mollicute infection after lung transplantation and the need for better screening and management protocols.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Transplant

DOI

EISSN

1600-6143

Publication Date

April 2024

Volume

24

Issue

4

Start / End Page

641 / 652

Location

United States

Related Subject Headings

  • Ureaplasma Infections
  • Surgery
  • Risk Factors
  • Retrospective Studies
  • Mycoplasma
  • Lung Transplantation
  • Humans
  • Adult
  • 3204 Immunology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tam, P. C. K., Hardie, R., Alexander, B. D., Yarrington, M. E., Lee, M. J., Polage, C. R., … Baker, A. W. (2024). Risk factors, management, and clinical outcomes of invasive Mycoplasma and Ureaplasma infections after lung transplantation. Am J Transplant, 24(4), 641–652. https://doi.org/10.1016/j.ajt.2023.08.019
Tam, Patrick C. K., Rochelle Hardie, Barbara D. Alexander, Michael E. Yarrington, Mark J. Lee, Chris R. Polage, Julia A. Messina, et al. “Risk factors, management, and clinical outcomes of invasive Mycoplasma and Ureaplasma infections after lung transplantation.Am J Transplant 24, no. 4 (April 2024): 641–52. https://doi.org/10.1016/j.ajt.2023.08.019.
Tam PCK, Hardie R, Alexander BD, Yarrington ME, Lee MJ, Polage CR, et al. Risk factors, management, and clinical outcomes of invasive Mycoplasma and Ureaplasma infections after lung transplantation. Am J Transplant. 2024 Apr;24(4):641–52.
Tam, Patrick C. K., et al. “Risk factors, management, and clinical outcomes of invasive Mycoplasma and Ureaplasma infections after lung transplantation.Am J Transplant, vol. 24, no. 4, Apr. 2024, pp. 641–52. Pubmed, doi:10.1016/j.ajt.2023.08.019.
Tam PCK, Hardie R, Alexander BD, Yarrington ME, Lee MJ, Polage CR, Messina JA, Maziarz EK, Saullo JL, Miller R, Wolfe CR, Arif S, Reynolds JM, Haney JC, Perfect JR, Baker AW. Risk factors, management, and clinical outcomes of invasive Mycoplasma and Ureaplasma infections after lung transplantation. Am J Transplant. 2024 Apr;24(4):641–652.
Journal cover image

Published In

Am J Transplant

DOI

EISSN

1600-6143

Publication Date

April 2024

Volume

24

Issue

4

Start / End Page

641 / 652

Location

United States

Related Subject Headings

  • Ureaplasma Infections
  • Surgery
  • Risk Factors
  • Retrospective Studies
  • Mycoplasma
  • Lung Transplantation
  • Humans
  • Adult
  • 3204 Immunology
  • 3202 Clinical sciences